Product NDC: | 0378-6628 |
Proprietary Name: | Eprosartan Mesylate |
Non Proprietary Name: | eprosartan mesylate |
Active Ingredient(s): | 400 mg/1 & nbsp; eprosartan mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-6628 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202012 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120307 |
Package NDC: | 0378-6628-91 |
Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-6628-91) |
NDC Code | 0378-6628-91 |
Proprietary Name | Eprosartan Mesylate |
Package Description | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-6628-91) |
Product NDC | 0378-6628 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | eprosartan mesylate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120307 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | EPROSARTAN MESYLATE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |